Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride channel accessory 3 pseudogene (CLCA3P) is a transcribed pseudogene belonging to the calcium-sensitive chloride conductance protein family[3][4][8]. In humans, the transcript contains several nonsense codons, making it subject to nonsense-mediated mRNA decay and it is not believed to encode a functional protein[1][3][8]. While proteins in this family can be functional in other species (such as mice), and CLCA3 homologues participate in the regulation of chloride ion transport and may contribute to mucus secretion in goblet cells, the human CLCA3P is likely a non-functional processed pseudogene and not considered a therapeutic target in humans[1][2][3][4]. Most references indicate that it does not produce a protein in humans, though some older or less-confirmed reports suggest the possibility of expression, but this remains unverified[1][2]. As such, the gene has no established drug interactions, mechanisms of action, biomarker roles, or relevance for safety assessment in drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride channel accessory 3 pseudogene (CLCA3P).